Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Salidroside combined mesenchymal stem cell injection for cardiomyopathy and preparation method thereof

A technology of salidroside and mesenchymal stem cells, which is applied in the field of medicine, can solve the problems of survivors of cerebrovascular accident who cannot take care of themselves completely, and achieve the effect of fast onset of action, easy-to-obtain and simple manufacturing raw materials

Inactive Publication Date: 2019-11-08
杭州荣泽生物科技集团有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Cardiovascular and cerebrovascular disease is a common disease that seriously threatens the health of human beings, especially middle-aged and elderly people. Even with the most advanced and perfect treatment methods, more than 50% of cerebrovascular accident survivors still cannot take care of themselves completely

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the manufacturing raw materials of the salidroside combined with mesenchymal stem cell injection for cardiomyopathy include high concentration salidroside, Sodium chloride, antioxidant, cinnamon glycosides and water for injection, the parts by weight of the raw materials for the manufacture of the salidroside joint mesenchymal stem cell injection are umbilical cord mesenchymal stem cells 1.0×10^7 / kg, high concentration red 1 part of sedroside, 10 parts of sodium chloride, 3 parts of antioxidant, 3 parts of cinnamon glycoside, and then add water for injection to 1000 parts.

[0026] A preparation method of salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the preparation method of said salidroside combined mesenchymal stem cell injection for cardiomyopathy comprises the following steps:

[0027] (1) First select a certain mass fraction of Rhodiola rosea crude extra...

Embodiment 2

[0040] A salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the manufacturing raw materials of the salidroside combined with mesenchymal stem cell injection for cardiomyopathy include high concentration salidroside, Sodium chloride, antioxidant, cinnamon glycosides and water for injection, the parts by weight of the raw materials for the manufacture of the salidroside joint mesenchymal stem cell injection are 5.0×10^7 / kg of umbilical cord mesenchymal stem cells, high concentration red 2 parts of sedroside, 12 parts of sodium chloride, 5 parts of antioxidant, 5 parts of cinnamyl glycoside, and then add water for injection to 1000 parts.

[0041] A preparation method of salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the preparation method of said salidroside combined mesenchymal stem cell injection for cardiomyopathy comprises the following steps:

[0042] (1) First select a certain mass fraction of Rhodiola rosea crude e...

Embodiment 3

[0055] A salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the manufacturing raw materials of the salidroside combined with mesenchymal stem cell injection for cardiomyopathy include high concentration salidroside, Sodium chloride, antioxidant, cinnamyl alcohol glycoside and water for injection, the parts by weight of the raw materials for the manufacture of the salidroside joint mesenchymal stem cell injection are 2.5×10^7 / kg of umbilical cord mesenchymal stem cells, high concentration red 1.5 parts of sedroside, 11 parts of sodium chloride, 4 parts of antioxidant, 4 parts of cinnamon glycosides, and then add water for injection to 1000 parts.

[0056] A preparation method of salidroside combined with mesenchymal stem cell injection for cardiomyopathy, the preparation method of said salidroside combined mesenchymal stem cell injection for cardiomyopathy comprises the following steps:

[0057] (1) First select a certain mass fraction of Rhodiola ros...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a salidroside combined mesenchymal stem cell injection for cardiomyopathy and a preparation method thereof. The salidroside combined mesenchymal stem cell injection for cardiomyopathy comprises raw materials in parts by weight as follows: 1.0-5.0*10^7 / kg of umbilical cord mesenchymal stem cells, 1-2 parts of high-concentration salidroside, 10-12 parts of sodium chloride, 3-5 parts of an antioxidant, cinnamyl alcohol and injection water. The production raw materials are simple and easy to obtain, the production method is convenient to implement, and mass production of the salidroside combined mesenchymal stem cell injection can be realized; and the salidroside injection can be more quickly and effective for patients by injection, can take effect more quickly on acutecardiovascular disease and can control acute and severe cardiovascular disease in a short time.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an injection of salidroside combined with mesenchymal stem cells for cardiomyopathy and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular disease is a common disease that seriously threatens the health of human beings, especially middle-aged and elderly people. Even with the most advanced and perfect treatment methods, more than 50% of cerebrovascular accident survivors cannot fully take care of themselves. Cardiovascular and cerebrovascular diseases have the characteristics of "high morbidity, high mortality, high disability rate, high recurrence rate, and many complications" - "four highs and one more". At present, there are more than 270 million patients with cardiovascular and cerebrovascular diseases in my country . [0003] Rhodiola rosea is a perennial herbaceous plant, which mainly grows in areas with an altitude of 1600-4000 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/28A61K31/7032A61K9/08A61P9/04
CPCA61K9/0019A61K9/08A61K31/7032A61K35/28A61K47/02A61P9/04A61K2300/00
Inventor 陈相波雷鸣田朋飞应荣
Owner 杭州荣泽生物科技集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com